Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Arm Holdings: The Narrative Can’t Justify The Current Share Price (NASDAQ:ARM)

22 September 2026

Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria Transcript

22 September 2026

PGIM Quant Solutions International Equity Fund Q2 2026 Commentary

22 September 2026

Pain of NHS whistleblowers as call for Lucy Letby retrial grows louder

22 September 2026

Wealthfront Is Good Value As Further Rate Hikes Loom (NASDAQ:WLTH)

22 September 2026
Facebook X (Twitter) Instagram
Business Tuesday, Sep 22
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » PGIM Quant Solutions International Equity Fund Q2 2026 Commentary
News

PGIM Quant Solutions International Equity Fund Q2 2026 Commentary

thebusinesstimes.co.ukBy thebusinesstimes.co.uk22 September 20260 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Share
Facebook Twitter LinkedIn Pinterest Email

PGIM Investments, a subsidiary of PFI, is an investment adviser and the investment manager to all PGIM US open-end investment companies and manager or administrator to closed-end investment companies. Note: This account is not managed or monitored by PGIM Investments, and any messages sent via Seeking Alpha will not receive a response. For inquiries or communication, please use PGIM Investments’ official channels.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Arm Holdings: The Narrative Can’t Justify The Current Share Price (NASDAQ:ARM)

Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria Transcript

Pain of NHS whistleblowers as call for Lucy Letby retrial grows louder

Wealthfront Is Good Value As Further Rate Hikes Loom (NASDAQ:WLTH)

Your Lunch Today Proves What The Fed Can’t Really Fix (NYSEARCA:SPY)

BrainsWay: Execution Isn’t The Problem, Market Size Is (NASDAQ:BWAY)

Pfizer: Stagnant Dividends At Rich Yields – Income Before Appreciation (NYSE:PFE)

George Risk Industries: Small In Size, Strong In Performance (OTCMKTS:RSKIA)

TriplePoint Venture Growth Offers A High Double-Digit Total Return Potential (NYSE:TPVG)

Editors Picks

Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria Transcript

22 September 2026

PGIM Quant Solutions International Equity Fund Q2 2026 Commentary

22 September 2026

Pain of NHS whistleblowers as call for Lucy Letby retrial grows louder

22 September 2026

Wealthfront Is Good Value As Further Rate Hikes Loom (NASDAQ:WLTH)

22 September 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

Your Lunch Today Proves What The Fed Can’t Really Fix (NYSEARCA:SPY)

22 September 2026

BrainsWay: Execution Isn’t The Problem, Market Size Is (NASDAQ:BWAY)

22 September 2026

Pfizer: Stagnant Dividends At Rich Yields – Income Before Appreciation (NYSE:PFE)

22 September 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.